The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
A Hot Debate: Perspectives on Benefit and Risk From Patients Across Diseases
Deborah E. Collyar
Patient Advocates In Research (PAIR), United States
This session provides a look at how regulators, companies, and patients can work together to discuss the benefits and risks of emerging products that can lead to better patient outcomes.
Learning Objective : 1) Develop an understanding of how patient preferences can be used to inform benefit-risk assessments
2) Develop an understanding of the properties of patient preference methods and the implications of these properties for use of patient preference information for regulatory purposes
Benefit- Risk Communication: Lessons from Patients
Dinah Duarte, PharmD, MSc
Scientific Evaluation Unit, Directorate of Medicinal Products
PREFERing to Advocate for Patient Preferences
Rebecca A. Noel, DrPH
Global Benefit-Risk Lead, Global Patient Safety
Eli Lilly and Company, United States
Living with Tuberous Sclerosis Complex (TSC): A Case Study
Tuberous Sclerosis Alliance, United States